Remove 2021 Remove Degenerative Disc Disease Remove Treatment
article thumbnail

Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion

OrthoSpineNews

Food and Drug Administration (FDA) premarket approval (PMA) of PearlMatrix P-15 Peptide Enhanced Bone Graft as a Class III drug-device combination product for use in single-level transforaminal lumbar interbody fusion (TLIF) surgery in adult patients with degenerative disc disease (DDD).

article thumbnail

NovoPulse- Where Recovery Meets Performance

The Evidence Based Chiropractor

Reaching a state of maximum therapeutic improvement, which only represents a partial recovery that has fallen short of expectations, causes us as clinicians to consider seeking other treatment strategies for the patient. I believe that this treatment was a major contributor to the successful rehab of my shoulder."